Displaying 1 - 1 of 1
| Active Ingredient | METOCLOPRAMIDE |
| Therapeutic Class | GI PROKINETIC AGENTS |
| Indications |
Facilitation of small bowel intubation in X -ray procedures. Esophageal reflux. Vomiting associated with cytotoxic agents. |
| Caution | Restlessness, drowsiness, dizziness, fatigue, insomnia, headache. Exercise caution in activities requiring mental alertness. c.f. prescribing in renal disease p. 32. Avoid use with alcohol More ... |
| Dose Range | Adult: Tabs:5-10mg 3 times daily . Pediatric: Oral 0.3-0.75mg/kg p er day in 3-4 divided doses. Intravenous: 2.5-10mg as a single dose (0.1mg/kg as a single dose in children under 6 y ears). |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |